Skip to main content

Catalogue Numbers for GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface

GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface

.035" Guidewire 

Catalogue Number 

Endoprosthesis 

Labeled

Diameter (mm) 

Endoprosthesis 
Length (cm) 
Catheter 
Length (cm) 
Recommended 
Vessel Diameter§ (mm) 
Device Profile (Fr) 

Recommended  Balloon

Diameter for Device

Touch-upII (mm) 

PAHR050202E
2.5 
120 
4.0–4.7 
PAHR050502E 
5.0
120
4.0–4.7 
7
5
PAHR050702E  
5
7.5
120
4.0–4.7 
7
5
PAHR051002E  
5
10.0
120
4.0–4.7 
7
5
PAHR051502E  
15.0
120
4.0–4.7 
7
5
PAHR052502E   
5
25.0
120
4.0–4.7 
7
5
PAHR060201E  
6
2.5
75
4.8–5.5 
7
6
PAHR060202E  
6
2.5
120
4.8–5.5 
7
6
PAHR060501E  
6
5.0
75
4.8–5.5 
7
6
PAHR060502E  
6
5.0
120
4.8–5.5 
7
6
PAHR060702E
6
7.5
120
4.8–5.5 
7
6
PAHR061001E  
6
10.0
75
4.8–5.5 
7
6
PAHR061002E  
6
10.0
120
4.8–5.5 
7
6
PAHR061501E  
6
15.0
75
4.8–5.5 
7
6
PAHR061502E  
6
15.0
120
4.8–5.5 
7
6
PAHR062502E     
6
25.0
120
4.8–5.5 
7
6
PAHR070201E  
7
2.5
75
5.6–6.5 
8
7
PAHR070202E  
7
2.5
120
5.6–6.5 
8
7
PAHR070501E  
7
5.0
75
5.6–6.5 
8
7
PAHR070502E  
7
5.0
120
5.6–6.5 
8
7
PAHR070702E
7
7.5
120
5.6–6.5 
8
7
PAHR071001E  
7
10.0
75
5.6–6.5 
8
7
PAHR071002E  
7
10.0
120
5.6–6.5 
8
7
PAHR071501E  
7
15.0
75
5.6–6.5 
8
7
PAHR071502E  
7
15.0
120
5.6–6.5 
8
7
PAHR072502E     
7
25.0
120
5.6–6.5 
8
7
PAHR080201E  
8
2.5
75
6.6–7.5 
8
8
PAHR080202E  
8
2.5
120
6.6–7.5 
8
8
PAHR080501E  
8
5.0
75
6.6–7.5 
8
8
PAHR080502E 
8
5.0
120
6.6–7.5 
8
8
PAHR080702E  
8
7.5
120
6.6–7.5 
8
8
PAHR081001E  
8
10.0
75
6.6–7.5 
8
8
PAHR081002E
8
10.0
120
6.6–7.5 
8
8
PAHR081501E
8
15.0
75
6.6–7.5 
8
8
PAHR081502E  
8
15.0
120
6.6–7.5 
8
8
PAHR082502E
8
25.0
120
6.6–7.5 
8
8
PAHR090502E
9
5.0
120
7.6–8.5 
8
9
PAHR090702E 
9
7.5
120
7.6–8.5 
8
9
PAHR091002E  
9
10.0
120
7.6–8.5 
8
9
PAHR091502E
9
15.0
120
7.6–8.5 
8
9
PAHR100502E
10
5.0
120
8.6–9.5 
8
10
PAHR101002E
10
10.0
120
8.6–9.5 
8
10
PAHR101502E 
10
15.0
120
8.6–9.5 
8
10
PAHR110502E 
11
5.0
120
9.6–10.5 
10
12
PAHR111002E
11
10.0
120
9.6–10.5 
10
12
PAHR130502E  
13
5.0
120
10.6–12.0 
10 
14
PAHR131002E 
13
10.0
120
10.6–12.0 
10 
14

GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface

.014/.018" Guidewire 

Catalogue Number 

Endoprosthesis

Labeled Diameter (mm) 

Endoprosthesis 
Length (cm) 
Catheter 
Length (cm) 
Recommended 
Vessel Diameter§ (mm) 
Device Profile (Fr) 

Recommended Balloon

Diameter for

Device Touch-upII (mm) 

PAJR050202E 
5
2.5
120
4.0–4.7 
6
5
PAJR050502E  
5
5.0
120
4.0–4.7 
6
5
PAJR050702E
5
7.5
120
4.0–4.7 
6
5
PAJR051002E 
5
10.0
120
4.0–4.7 
6
5
PAJR051502E
5
15.0
120
4.0–4.7 
6
5
PAJR052502E
5
25.0
120
4.0–4.7 
6
5
PAJR060202E 
6
2.5
120
4.8–5.5 
6
6
PAJR060502E
6
5.0
120
4.8–5.5 
6
6
PAJR060702E
6
7.5
120
4.8–5.5 
6
6
PAJR061002E 
6
10.0
120
4.8–5.5 
6
6
PAJR061502E
6
15.0
120
4.8–5.5 
6
6
PAJR062502E
6
25.0
120
4.8–5.5 
6
6
PAJR070202E
7
2.5
120
5.6–6.5 
7
7
PAJR070502E  
7
5.0
120
5.6–6.5 
7
7
PAJR070702E 
7
7.5
120
5.6–6.5 
7
7
PAJR071002E 
7
10.0
120
5.6–6.5 
7
7
PAJR071502E 
7
15.0
120
5.6–6.5 
7
7
PAJR072502E 
7
25.0
120
5.6–6.5 
7
7
PAJR080202E 
8
2.5
120
6.6–7.5 
7
8
PAJR080502E  
8
5.0
120
6.6–7.5 
7
8
PAJR080702E  
8
7.5
120
6.6–7.5 
7
8
PAJR081002E
8
10.0
120
6.6–7.5 
7
8
PAJR081502E 
8
15.0
120
6.6–7.5 
7
8
PAJR082502E  
8
25.0**
120
6.6–7.5 
7
8

* As used by Gore, PROPATEN Bioactive Surface refers to Gore’s proprietary CBAS® Heparin Surface 
Labeled device diameters and lengths are nominal. 
 Ensure the guidewire is the appropriate size (see Instructions for Use) and has a length at least twice that of the delivery catheter. 
§ Recommended endoprosthesis compression within the vessel is approximately 5 – 20%. 
II For the 11 and 13 mm diameter devices, balloon inflation pressure should not exceed 8 atm. 
 The 13 mm diameter device is not compatible with the 10 Fr COOK® FLEXOR® CHECK-FLO® sheath.
** The 8 mm x 25 cm device is not compatible with the 7 Fr COOK® FLEXOR® CHECK-FLO® sheath.

Sizing, availability and pricing varies by country. 

IFU Consult instructions

Refer to Instructions for Use at eifu.goremedical.com for a complete description of all applicable indications, warnings, precautions and contraindications for the markets where this product is available. RXOnly

INDICATIONS FOR USE IN EUROPE: The GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface is indicated for the treatment of:

  • de novo or restenotic lesions in the iliac arteries
  • de novo or restenotic lesions in the superficial femoral artery and proximal popliteal artery
  • in-stent restenotic lesions in the superficial femoral artery and proximal popliteal artery
  • stenosis or thrombotic occlusion at the venous anastomosis of synthetic arteriovenous (AV) access grafts and in the venous outflow of dialysis access circuits, including the central veins
  • popliteal artery aneurysms and isolated visceral artery aneurysms
  • traumatic or iatrogenic vessel injuries in arteries that are located in the chest cavity, abdominal cavity, or pelvis (except for aorta, coronary, innominate, carotid, vertebral, and pulmonary arteries)

CONTRAINDICATIONS:

  • Non-compliant lesions where full expansion of an angioplasty balloon catheter was not achieved during pre-dilatation, or where lesions cannot be dilated sufficiently to allow passage of the delivery system.
  • Do not use the GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface in patients with known hypersensitivity to heparin, including those patients who have had a previous incident of Heparin-Induced Thrombocytopenia (HIT) type II. 
Product may not be available in all countries. Please check with your Gore representative for availability.